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Abstract 
The impact of melasma was not only about health problems, however, it also about the social impact that 
becomes a new problem in the management of melasma. This study was aimed to investigate Quality of Life in 
some type of melasma. This study was a cross-sectional study on 82 patients diagnosed with melasma in the 
dermatovenerology clinic in two samples of Private hospital from January-April 2019 that was taken by 
accidental sampling method. All data of this study were analyzed by descriptive analysis, then the quality of life 
and clinical presentation were analyzed by logarithmic transformations on Melas-QoL and T-independent Test. 
There are more participants had malar melasma (76.83%) than the centrofacial melasma (23.17%). T-
Independent Tests showed that there was no difference in the quality of life among each type of melasma (P-
value <0.05). However, there is a significant difference between the perceptions among each type of melasma 
(P-value = 0.026), where there are more participants who feel disturbed by the centrofacial melasma (84.2%) 
than malar melasma (58.7%). There is no difference in the quality of life among each type of melasma. 
However, patients with centrofacial melasma are more disturbed on their skin than malar types. 
Keywords: entrofacial; Malar; Melas-QoL; Quality of Life. 
1. Introduction  
There are two types of pigmentation disorder include hypermelanosis and hypomelanosis. Melasma is one of 
pigmentation disorder which unknown etiology and pathogenesis. Melasma is acquired hypermelanosis which 
has the rash-like symmetric or confluence or separated light to dark brown along exposed skin against UV [1–
4].  In the past, melasma also known as chloasma, the mask of pregnancy, liver spots, chloasma gravidarum, and 
chloasma virgium [1,3,5,7]. Chloasma comes from the Greek, chloazein, which means "become green" [8].  
------------------------------------------------------------------------ 
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Melas, also from Greek, means "black". Because pigmentation never appears green, melasma has a more 
appropriate term [3,5,6].  There some type of melasma based on its domination in the face includes centrofacial, 
malar, and mandibula. Based on the type of melasma, the most common melasma was centrofacial 50-80% 
included the forehead, nose, upper lips, without philtrum, cheek, and chin. Malar limited in malar cheek in the 
face while mandibular was the line in jaw and chin. Mandibula might be found in older persons and associated 
with severe photodamage [9]. The incidence of Melasma was high. In Nepal, the incidence of melasma was high 
in 2008 amount of 546 patient of dermatologists was diagnosed melasma [10]. On the other hand, in Indonesia 
there was not a general study about melasma but, the separated study had been conducted. Based on the 
Dermatology and Venerology Department of RS. Dr. M. Djamil Padang, there were 9.5% from 1.622 
consultations for 2011-2014 which were diagnosed Melasma [11]. While according to a study in RSU H. Adam 
Malik Medan, the most common pigmentation disorder was melasma, followed by Post-Inflammatory 
Hyperpigmentation [4].  Melasma does not only affect a healthy profile but it also affects Quality of Life 
especially social aspect which became a new challenge in the treatment of melasma. The reducing Quality of 
Life in Melasma patient was shown in the study by Ikino and his colleagues (2015) in Universidade Federal de 
Santa Catarina Hospital reported there are significant emotional impact in Quality of Life from Melasma Patient 
[12] while Tursina and his colleagues (2017) in one of private dermatologist clinic report similar result whether 
there was correlation between severity of melasma and quality of life [13].  Based on the information above, 
Quality of Life in Melasma patient was an important aspect of the treatment of Melasma patient. However, the 
severity of melasma was difficult to realize in the clinical setting. So, this study was aimed to investigate 
Quality of Life in some type of melasma using the simple classification from the type of melasma. 
2. Methods 
This study was a cross-sectional study among adult woman which was outpatient of dermatovenerology clinic in 
two samples of Private hospital from January-April 2019. From each hospital, the samples were gotten by the 
Accidental sampling technique. Information collected socio-demographic characteristics, Quality of Life, and 
Type of Melasma.  There were 82 participants as samples. All of the participants were diagnosed by clinical 
presentation that was fulfill inclusion criteria includes woman and aged older than 18 years old. The clinical 
presentation includes light or dark brown macules with firm borders with irregular edges in areas that are often 
exposed to ultraviolet rays, grayish or bluish tones especially in the dermal type [3,5,7,8]. Socio-demographic 
characteristics of participants included age, last education, and occupation. The age was classified into 21-30 
years old, 31-40 years old, 41-50 years old, 51-60 years old, and 61-70 years old. The last education was 
classified into primary school, junior high school, senior high school, diploma 3, bachelor’s degree, and master. 
While the occupation was classified as civil servant, housewife, private employees, and others.   Quality of Life 
was derived by Melas-QoL Quesionner. It had 10 questions, each question had 7 options which were ranged 
from 1 (Not bothered) to 7 (bothered to all the time). The highest score which could be gotten by this questioner 
was 70 and the lowest was 10. Type of Melasma was classified into centrofacial, mandibular, and malar type 
based on the clinical presentation. Centrofacial included the forehead, nose, medial cheek, lower nose, and chin 
while malar included nose and lateral cheek, and Mandibular only distributed in mandibular. Total Melas-QoL 
score in this study was express in Mean ± SD. The comparison of Total Melas-QoL Score from each type of 
melasma was analyzed by Independent T-Test. If the normality of Total Melas-QoL didn't distribute normally, it 
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was transformed by logarithmic transformation. Each answer from each question was analyzed by Mann-
Whitney Test. All test had confidence interval at 95% (α = 0.05) 
3. Results and Discussion 
3.1. Prevalence of Melasma 
The prevalence of the type of melasma in two private hospitals in this study was shown in the table below. 
Table 1: Prevalence of Each Type of Melasma 
Type of Melasma Frequency Percentage 
Centrofacial 19 23.17 
Malar 63 76.83 
Total 82 100.00 
Based on table above, the prevalence of malar melasma (76.83%) was higher than centrofacial (76.83%). There 
are 19 participants which had centrofacial type from 82 participants while remain 63 participants had malar type 
of melasma. Melasma is an abnormality in the skin that experiences hyperpermelanosis (melanoderma) which is 
an increase in the production of melanin pigment in the skin and melanocyte cells increment, generally 
symmetrical, confluence or scattered, in the form of light brown to dark brown macules, on areas exposed to 
ultraviolet light with predilection on cheeks , forehead, upper lip, nose and chin area [1,3,5–7]. The exact cause 
of melasma is still unknown and the pathogenesis is unclear [1,3,5–8]. However, there are several risk factors 
that take a role in pathogenesis of melasma includes genetic, UV radiation, hormonal, drugs, race, cosmetic 
[6,7], inflammation, stem cell factor, neural, vascular components [8], pregnancy, oral contraception, estrogen 
replacement therapy, ovarian dysfunction, ovarian tumor, nutrition, thyroid dysfunction, phototoxic drugs, 
epilepsy [1,3,6], and steroid [3]. These risk factors affect the melanogenesis process [3,5–8].  Melasma is most 
common in women (90%) than in men (10%) [6]. The sex ratio of melasma in Indonesia is 24:1, especially seen 
in women of childbearing age with a direct history of long-term intensity sun exposure, at the age of 30-44 years 
is the highest incidence, this disorder can affect pregnant women, women using oral contraceptives, cosmetic 
users, drug users, and others [1,3,5–7,14]. There are several types of melasma based on clinical presentations, 
histopathologic view, and wood light examination [7].  Based on the clinical presentation, melasma is classified 
into centrofacial (63%),malar (21%), and mandibular (16%) [1,5,7,1,5,7].  On the other hand, based on the 
histopathologic view, it is classified into epidermal, dermal, and mix type. While based on the wood 
examination, it was classified the same as a histopathologic view but there is unclear type as an additional that is 
unclear lesion efflorescent when it is lighted using wood lamp [5–7]. 
3.2. Social-Demographic Characteristics 
The socio demographic characteristic of participants in this study was shown in table below. 
 
American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2019) Volume 60, No  1, pp 149-158 
152 
Table 2: Socio-Demographic Characteristics of Participants 
Characteristics Type of Melasma Total 
Centrofacial (n=19) Malar (n=63) 
Age 
21-30  5 (26.3) 12 (19) 17 
31-40 5 (26.3) 15 (23.8) 20 
41-50  8 (42.1) 23 (36.5) 31 
51-60  1 (5.3) 11 (17.5) 12 
61-70  0 (0) 2 (3.2) 2 
Last Education 
Primary School 2 (10.5) 5 (7.9) 7 
Junior High School 0 (0) 3 (4.8) 3 
Senior High School 8 (42.1) 17 (27.0) 25 
Diploma 3 (Associated degree) 4 (21.1) 17 (27.0) 21 
Bachlor’s degree 5 (26.3) 15 (23.8) 20 
Master 0 (0) 6 (9.5) 6 
Occupation 
Civil Servant  1 (5.3) 14 (22.2) 15 
Housewife 4 (21.1) 18 (28.6) 22 
Private employees 5 (26.3) 27 (42.9) 32 
Others 9 (47.4) 4 (6.3) 13 
Based on the table above, the peak age of centrofacial or malar melasma was between 41-50 years old. While 
last education level of participant among centrofacial type was the most common in senior high school (42.1%) 
and Senior High School - Diploma 3 (Associated degree) was the most common last education in malar type 
which amount of 17 participants in each level of education (27%). Furthermore, the most occupation in 
centrofacial type did not describe in this study amount of 9 participants (47.7%) but, in malar type, the most 
common occupation of participants in this study was private employees which were 27 participants (42.9%). 
3.3. Comparison of Total Melas-QoL Score  
Belong to the previous decade, evaluations of medical therapy procedures only based on the objective clinical 
recovery criteria. However, in the recent decade, reported subjective factors such as patient experience, habits, 
and disease severity have made it possible to clinically determine the characteristics of the disease course and 
the effects of therapy. These factors are categorized as Quality of Life (QoL). Quality of Life (QoL) related to 
the Health (Health-Related Quality of Life (HR-QoL)) is part of Patient-reported outcomes (PROs) that have 
substantive importance in research as well as medical care. HRQoL reflects the patient's health condition in 
physical, social, emotional and functional dimensions [15]. The evaluation for the Health-Related Quality of 
Life (HRQoL), there are two types of psychometric questionnaires namely generic (general) and specific. 
General instruments are multidimensional and are developed to evaluate the impact caused by a disease in 
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various aspects of life as a whole. The disadvantage of using such instruments is that they are not sensitive in 
detecting specific aspects of the suction quality in patients who have certain diseases. Specific instruments can 
also be multidimensional and can assess certain aspects of the quality of life of certain individuals, with 
emphasis on symptoms, disability, or limitations related to certain diseases. The disadvantage of this instrument 
is the difficulty of understanding the phenomenon generally [16]. The Melasma Quality of Life (Melas-QoL) 
scale is a useful tool in assessing the quality of life for patients that have melasma. Initially, the instrument was 
developed in English, recently the questionnaire was translated into various languages including Spanish, 
Portuguese, Brazilian, French, and Turkish. When these instruments are translated into other languages, 
attention must be focused on cross-cultural adaptation and appropriate methods of translation and validation to 
create accurately translated instruments [17]. Total Melas-QoL score which was collected from each type of 
melasma was analyzed by descriptive statistic and normality test. The figure above was shown the comparison 
of the total Melas-QoL score in each type of melasma. Due to the total Melas-QoL Score did not distribute 
normally, Total Melas-QoL Score was transformed logarithmically. 
 
Figure 1: Comparison of Total Melas-QoL Score in Each Type of Melasma 
Based on the figure above, the average from the Total Melas-QoL score was higher than on the malar type. 
However, the dispcersion of the data from centrofacial was wider than in the malar type. The dispersion which 
was used in this study were Standard deviation. Furthermore, the transformation of the total Melas-QoL score 
was analyzed by Independent T-Test. The result of the Independent T-Test was shown in the table below. 
Table 3: Analysis of Independent T-Test for Total Melas-QoL Score in Each Type of Melasma 
Type of 
Melasma 
Log  ̅  
(Total Melas-QoL Score) 
Standar Error of 
Mean (SEM) 
95% CI of Mean 
P Value Upper 
Limit 
Lower 
Limit 
Centrolfasial 1.48 0.05 37,84 24,10 0.251 
Malar 1.42 0.02 28,79 24,03 
Based on the figure above, the average from the Total Melas-QoL score was higher than on the malar type. 
However, the dispcersion of the data from centrofacial was wider than in the malar type. The dispersion which 
was used in this study were Standard deviation. Furthermore, the transformation of the total Melas-QoL score 
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was analyzed by Independent T-Test. The result of the Independent T-Test was shown in the table below. 
Overall Quality of Life from each type of melasma was not different. Whereas each item from the questioner 
was also analyzed by the Mann-Whitney test and it was shown in the table below. 
Table 4: Analysis of Mann-Whitney Test for Each Item of Melas-QoL in Each Type of Melasma 
Question Item P value 
Q1 The appearance of your skin condition 0.026 
Q2 Frustration about your skin condition 0.325 
Q3 Embarrassment about your skin condition 0.492 
Q4 Feeling depressed about your skin condition 0.646 
Q5 The effects of your skin condition on your interaction with other people 0.677 
Q6 The effects of your skin condition on your desire to be with people 0.569 
Q7 Your skin condition making it hard to show affection 0.678 
Q8 Skin discoloration making you feel unattractive to others 0.139 
Q9 Skin discoloration making you feel less vital or productive 0.060 
Q10 Skin discoloration making you sense of freedom 0.695 
Based on the table above, there was only a question which had a significant difference among the type of 
melasma. It was the first question about the appearance of their skin appearance which had p-value 0.026 (P-
value < 0.05). Other questions from the Melas-QoL Quesionner did not have differences among the type of 
melasma due to p-value > 0.05. In the purpose of investigating the differences which were gotten from the 
Mann-Whitney test. The following tables will show the distribution of answers from each item of the questioner 
for each type of melasma. 
Table 5: Distribution of Participants’ Answers from Melas-QoL Quesionner in Group of Centrofacial 
Participants 
Item 
Answer (%) 
1 2 3 4 5 6 7 
The appearance of your skin 
condition 
1 
(5.3) 
1 
(5.3) 
0 
(0) 
1 
(5.3) 
4 
(21.1) 
2 
(10.5) 
10 
(52.6) 
Frustration about your skin 
condition 
6 
(31.6) 
1 
(5.3) 
0 
(0) 
3 
(15.8) 
5 
(26.3) 
1 
(5.3) 
3 
(15.8) 
Embarrassment about your 
skin condition 
6 
(31.6) 
3 
(15.8) 
0 
(0) 
1 
(5.3) 
3 
(15.8) 
2 
(10.5) 
4 
(21.1) 
Feeling depressed about your 
skin condition 
11 
(57.9) 
3 
(15.8) 
0 
(0) 
31.63 
(15.8) 
0 
(0) 
0 
(0) 
2 
(10.5) 
The effects of your skin 
condition on your interaction 
with other people 
7 
(36.8) 
4 
(21.1) 
0 
(0) 
0 
(0) 
7 
(36.8) 
0 
(0) 
1 
(5.3) 
The effects of your skin 
condition on your desire to be 
with people 
7 
(36.8) 
1 
(5.3) 
0 
(0) 
4 
(21.1) 
5 
(26.3) 
0 
(0) 
2 
(10.5) 
Your skin condition making it 
hard to show affection 
15 
(78.9) 
1 
(5.3) 
0 
(0) 
1 
(5.3) 
1 
(5.3) 
0 
(0) 
1 
(5.3) 
Skin discoloration making 
you feel unattractive to others 
4 
(21.1) 
1 
(5.3) 
0 
(0) 
4 
(21.1) 
6 
(31.6) 
1 
(5.3) 
3 
(15.8) 
Skin discoloration making 
you feel less vital or 
productive 
11 
(57.9) 
2 
(10.5) 
0 
(0) 
2 
(10.5) 
3 
(15.8) 
0 
(0) 
3 
(15.8) 
Skin discoloration making 
you sense of freedom 
9 
(47.4) 
2 
(10.5) 
0 
(0) 
3 
(15.8) 
3 
(15.8) 
0 
(0) 
2 
(10.5) 
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Based on table above, it could be observed that 52.6% of participants who had centrofacial melasma felt very 
distrubed about their apperance of skin condition and 31.6% of participants sometimes felt unattractive due to 
their skin discoloration. Whereas, There were 36.6% of participants who had centrofacial melasma felt neither 
frustrated nor embarrassed about their skin condition and 57.9% didn’t feel depression about their skin 
condition. While the most of participants who had centrofacial melasma did not effect on their interaction with 
other people (36.8%) or their desire to be with people (36.8%), did not make it hard to show affection (78 .9%), 
and did not make them feel less vital or productive (57.9%) or sense of freedom (47.4%). 
Table 6: Distribution of Participants’ Answers from Melas-QoL Quesionner in Group of Malar Participants 
Item 
Answer (%) 
1 2 3 4 5 6 7 
The appearance of your skin 
condition 
3 
(4.8) 
10 
(15.9) 
0 
(0) 
13 
(20.6) 
15 
(23.8) 
5 
(7.9) 
17 
(27.0) 
Frustration about your skin 
condition 
28 
(44.4) 
1 
(1.6) 
1 
(1.6) 
10 
(15.9) 
14 
(22.2) 
1 
(1.6) 
8 
(12.7) 
Embarrassment about your 
skin condition 
26 
(41.3) 
2 
(3.2) 
1 
(1.6) 
6 
(9.5) 
17 
(27.0) 
1 
(1.6) 
10 
(15.9) 
Feeling depressed about your 
skin condition 
41 
(65.1) 
6 
(9.5) 
1 
(1.6) 
6 
(9.5) 
6 
(9.5) 
1 
(1.6) 
2 
(3.2) 
The effects of your skin 
condition on your interaction 
with other people 
23 
(36.5) 
15 
(23.8) 
0 
(0) 
11 
(17.5) 
8 
(12.7) 
3 
(4.8) 
3 
(4.8) 
The effects of your skin 
condition on your desire to be 
with people 
23 
(36.5) 
8 
(12.7) 
0 
(0) 
17 
(27.0) 
8 
(12.7) 
4 
(6.3) 
3 
(4.8) 
Your skin condition making it 
hard to show affection 
52 
(82.5) 
3 
(4.8) 
1 
(1.6) 
3 
(4.8) 
3 
(4.8) 
0 
(0) 
1 
(1.6) 
Skin discoloration making 
you feel unattractive to others 
22 
(34.9) 
9 
(14.3) 
2 
(3.2) 
5 
(7.9) 
18 
(28.6) 
0 
(0) 
7 
(11.1) 
Skin discoloration making 
you feel less vital or 
productive 
49 
(77.8) 
6 
(9.5) 
0 
(0) 
3 
(4.8) 
3 
(4.8) 
0 
(0) 
2 
(3.2) 
Skin discoloration making 
you sense of freedom 
26 
(41.3) 
10 
(15.9) 
0 
(0) 
6 (9.5) 15 
(23.8) 
0 
(0) 
2 
(10.5) 
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Based on the table above, it could be observed that 27% of participants who had malar melasma felt very 
disturbed about their skin condition. However, there were 44.4% of participants who had malar melasma felt 
neither frustration nor embarrassment about their skin condition and 65.1% of participants who had malar 
melasma did not feel depressed due to their skin condition. While most of the participants who had malar 
melasma did not effect on their interaction with other people (36.5%) or their desire to be with people (36.5%), 
did not make it hard to show affection (82.5%), and did not make them feel unattractive (34.9%) or less vital or 
productive (77.8%) or sense of freedom (41.3%). The comparison of total Melas-QoL score in each type of 
melasma in the results of this study shows that there was a higher tendency of total Melas-QoL score in the 
centrofacial melasma then malar melasma. However, the One-way ANOVA test showed that there was no 
difference in total Melas-QoL score from each type of melasma statistically due to the p-value of the test was 
0.251 as shown in table 3 above.  Based on the Melas-QoL score in the table above, 95% of the Confidence 
interval for the quality of life of patients with centrofacial melasma was good-moderate and malar melasma was 
good. This value was obtained from the CI 95% value of total Melas-QoL score from each type of melasma then 
the value was categorized according to Tursina and his colleagues (2017) [13]. The result of this study report 
that there were no differences in quality of life between melasma types (sentimental and malar) among the 
participants. This was shown by the p-value that more than 0.05 (P-value = 0.251). However there was a 
significant difference in the answer of the first question between each group of sample about their skin 
condition, it was shown by the p-value of the first question in the table 4 above which is lower than 0.05 (p-
value = 0.026). Based on the table above the number of participants who had centrofacial melasma felt disturbed 
about their skin condition was 84.2% while there was 58.7% felt disturbed about their skin condition in the 
participant who had malar melasma. Melasma affects most of the participants' quality of life. It was reported by 
Ikino and his colleagues (2015) [12] in 51 melasma patients at the Universidade Federal de Santa Catarina 
Teaching Hospital reported that melasma affected the quality of life, especially the emotional aspects, including 
feelings of disruption (94.11%), frustration and shame (64.71%), and depression (52.94%) in conditions the 
skin. However, the social aspects do not show a significant effect.  More specifically, the severity of melasma 
affects the patient's quality of life. It was reported by Ali and his colleagues (2013) [18] by using the 
Dermatology Life Quality Index (DLQI) questioner to measure the quality of life and the Melasma Area 
Severity Index (MASI) to determine the severity of melasma in 100 patients who suffer melasma in the Mayo 
Hospital dermatology department from 2009 to 2010 showed similar result with this study where the decrease in 
quality of life is greater in women and the severity of melasma is more severe, this can be seen from the DLQI 
Score of 16.23 ± 5.35 in mild melasma, 19.32 ± 3.99 in moderate melasma, and 22.0 ± 2.0 in severe melasma. 
However, [19] reported that amount of 49 women who was diagnosed with melasma were referred to tertiary 
dermatology in Singapore using the Melas-QoL and DLQI questioner to measure quality of life and the MASI 
score to determine the severity of melasma showed opposite results where there was no correlation between the 
degree of melasma and quality patient's life as measured by Melas-QoL and DLQI. According to (Noor, 2008) 
[20] three factors influence the quality of measurement, namely the characteristics of the subject being 
measured, the person who measured it, and the measuring instrument used to measure the object. So, the reason 
for differences in the results of the study of [18] and [19] can be due to differences in the characteristics of the 
research subject. Referring to Ali and his colleagues (2013)  [18] reported that a greater reduction in quality of 
life in more severe melasma. Where the results of measuring the severity of melasma used the MASI score. The 
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MASI score consists of three components, namely Darkness, homogeneity, and the area involved. Whereas in 
this study, the clinical presentations were more emphasized than the severity of melasma, while the 
determination of the clinical presentations was only based on the area involved without considering the level of 
darkness or homogeneity. So that it is reasonable if there are differences in the results of measurements in each 
study because there are differences in the measuring instrument of the object under the study and differences in 
the characteristics of the subject being measured. 
4. Conclusion 
There were no significant differences between each type of melasma. However, there was a significant 
difference number of participants who are bothered about their skin appearance between participants who had 
centrofacial and malar type. 
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